Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TSD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,982
Award facts
- Contract value 100% obligated
- $10,981.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,981.59 by the Defense Logistics Agency for the supply of Dupixent 200 mg/1.14 mL syringes. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 16, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle that provides comprehensive global pharmaceutical support to military healthcare programs through December 2031.
The Defense Logistics Agency's Medical Supply Chain utilizes this IDC framework to procure a broad spectrum of pharmaceutical products and medical supplies necessary to support military treatment facilities and veteran healthcare systems worldwide. Dupixent, a specialty biologic medication, falls within the company's demonstrated portfolio of delivering specialty medications, brand-name drugs, and critical care materials across multiple therapeutic domains. AmerisourceBergen's selection through open competition underscores its capability to meet federal procurement requirements for essential pharmaceutical commodities supporting the Department of Defense's healthcare mission.
Quick answers
Who was awarded contract SPE2DR26F3TSD?
SPE2DR26F3TSD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F3TSD worth?
The government has obligated $10,982 on SPE2DR26F3TSD.
Is contract SPE2DR26F3TSD an order under another contract?
Yes. SPE2DR26F3TSD is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TSD competed?
The extent of competition for SPE2DR26F3TSD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award